×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world's major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Chemical Report Listings

Lymphoma Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Small molecule Products, Large molecule Products, Animal health), By Distribution Channel (Pharmacies, Grocery stores, Vitamin and health food stores), By Therapy Area (Alimentary/metabolic, Anti-parasitic, Anti-infectives, Blood and clotting, Cardiovascular, Dermatological, Genitourinary, Hormonal, Immunological, Musculoskeletal, Neurological, Oncology, Others), Countries and Companies Report

Lymphoma Drugs Market is projected to register a 8.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022454  |   No. of Pages: 195

Vial Cap Sealing Machines Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Cap Automatic Cap Sealing Machines, Semi-Automatic Vial Sealing Machine, Manual Vial Cap Sealing Machine), By End-User (Chemical, Pharmaceutical, Food & Beverages, Personal Care & Cosmetics, Others), Countries and Companies Report

Vial Cap Sealing Machines Market is projected to register a 5.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021100  |   No. of Pages: 182

Biologics Contract Manufacturing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (MABs, Recombinant Protein, Others), By Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), Countries and Companies Report

Biologics Contract Manufacturing Market is projected to register a 10.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00020569  |   No. of Pages: 199

Pharmaceutical Collaborative Robots Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications), By End-user (Pharmaceutical Companies, Research Laboratories), Countries and Companies Report

Pharmaceutical Collaborative Robots Market is projected to register a 12.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021458  |   No. of Pages: 190

Clinical Trial Equipment & Ancillary Solutions Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), Countries and Companies Report

Clinical Trial Equipment & Ancillary Solutions Market is projected to register a 8.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00020304  |   No. of Pages: 184

Sustained Release Excipients Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan), By Technology (Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation, Others), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Others), Countries and Companies Report

Sustained Release Excipients Market is projected to register a 8.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD0008942  |   No. of Pages: 200

Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Medication, Stem Cell Transplant, Blood Transfusion), Countries and Companies Report

Paroxysmal Nocturnal Hemoglobinuria Treatment Market is projected to register a 10.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021422  |   No. of Pages: 198

Retinal Vein Occlusion Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Disease (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion), By Type (Anti-vascular Endothelial Growth Factor, Corticosteroid Drugs, Others), By End-user (Hospital & Clinics, Retail Pharmacy, Others), Countries and Companies Report

Retinal Vein Occlusion Treatment Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021518  |   No. of Pages: 191

Cell and Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), Countries and Companies Report

Cell and Gene Therapy Bioanalytical Testing Services Market is projected to register a 8.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00020641  |   No. of Pages: 182

Cellulose Bioplastic Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Application (Packaging, Agriculture, Consumer Goods, Textile, Automotive & Transportation, Building & Construction, Others), By Product (Cellulose Butyrate, Cellulose Acetate, Cellulose Propionate, Others), Countries and Companies Report

Global Cellulose Bioplastic is forecast to reach $1112.7 Million in 2030 from $452 Million in 2024, registering a CAGR of 16.2%

Published On: November, 2024  |   Report Code: USD00027401  |   No. of Pages: 205